Related Experiment Video
Updated: Aug 14, 2026

Self-assembly of Complex Two-dimensional Shapes from Single-stranded DNA Tiles
Published on: May 8, 2015
Shape-selective recognition of a model Okazaki fragment by geometrically-constrained bis-distamycins
W H Gmeiner1, W Cui, D E Konerding
1Eppley Institute, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha 68198-6805, USA. bgmeiner@unmc.edu
Abstract:
Okazaki fragments represent interesting targets for the design of anticancer drugs because of their selective occurrence during DNA replication, a process often elevated in aggressive malignancies. Structural studies have indicated a bend occurs in the helical axis at the junction region (JR) that joins the DNA duplex region (DDR) and the RNA-DNA hybrid duplex region (HDR) of model Okazaki fragments. To identify a structural motif that provides a shape complementary to the Okazaki fragment minor groove, we have investigated the binding of geometrically-constrained bis-distamycins to a model Okazaki fragment, [OKA], with a sequence derived from the genome of simian virus 40 (SV40). Both the JR and the DDR of [OKA] contain consecutive A/T base pairs that could accommodate distamycin binding. Of the six bis-distamycins selected for analysis, the two with a para configuration of the distamycins on the benzene or pyridine scaffold bound [OKA] tightly (Kd approximately 10(-6) M from gel-shift assays; Kd approximately 10(-8) M from deltaT(M)) while the four with a meta orientation did not bind. The two mono-distamycins studied also did not bind [OKA]. Molecular modeling of the complex between the para bis-distamycin MT-9 and [OKA] revealed MT-9 adopted an S- shape complementary to the minor groove of the model Okazaki fragment.
Insights
Bis-distamycins targeting Okazaki fragments show promise as anticancer drugs. Specifically, para-configured bis-distamycins bind tightly to the Okazaki fragment minor groove, suggesting a potential therapeutic strategy.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Drug Discovery
Background:
- Okazaki fragments are crucial in DNA replication and elevated in cancers.
- Structural studies reveal a bend at the junction region (JR) of Okazaki fragments.
- This unique structure presents a potential target for anticancer drug design.
Purpose of the Study:
- To identify structural motifs that bind to the Okazaki fragment minor groove.
- To investigate the binding of geometrically-constrained bis-distamycins to model Okazaki fragments.
- To explore the potential of bis-distamycins as anticancer agents.
Main Methods:
- Synthesis and selection of six bis-distamycins with varying configurations.
- Gel-shift assays and deltaT(M) measurements to determine binding affinity (Kd).
- Molecular modeling to elucidate the binding complex structure.
Main Results:
- Para-configured bis-distamycins demonstrated tight binding to the model Okazaki fragment (Kd ~10^-6 to 10^-8 M).
- Meta-oriented bis-distamycins and mono-distamycins showed no significant binding.
- Molecular modeling revealed an S-shaped conformation of a para bis-distamycin (MT-9) fitting the minor groove.
Conclusions:
- Para-configured bis-distamycins are effective binders to the Okazaki fragment minor groove.
- The specific geometry of para bis-distamycins is critical for binding.
- These findings support the development of bis-distamycin derivatives as novel anticancer therapeutics targeting DNA replication.
More Related Videos
Related Concept Videos
Long-patch Base Excision Repair
Restarting Stalled Replication Forks
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...

